Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06039319 · ClinicalTrials.gov registry record
Acute Effects of Maternal Exercise and the Growth Restricted Pregnancy
A clinical trial of Fetal Growth Retardation and Placental Insufficiency, sponsored by University of Tennessee Graduate School of Medicine.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06039319: Completed study of Fetal Growth Retardation and Placental Insufficiency, sponsored by University of Tennessee Graduate School of Medicine.
NCT06039319 is a study of Fetal Growth Retardation and Placental Insufficiency that has completed, run by University of Tennessee Graduate School of Medicine. The registered enrollment target is 40 participants, below the 492-participant average among 3 other Fetal Growth Retardation trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06039319, a study of Fetal Growth Retardation and Placental Insufficiency, has completed, sponsored by University of Tennessee Graduate School of Medicine.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Objectives / Specific Aims * The purpose of this study is to investigate the acute effects of a single bout of moderate intensity maternal exercise on fetal well-being in a pregnancy affected by fetal growth restriction. Fetal well-being will be measured by biophysical profile (BPP), non-stress test (NST) and umbilical artery dopplers. * The hypothesis is that a single bout of maternal exercise will not significantly alter fetal well-being or fetal status.
Primary Outcome
Change in physiological assessment of umbilical artery dopplers systolic/diastolic ratio measured using ultrasound
Conditions Studied
Interventions
- OTHER Physical activity
Study Locations (1)
Tennessee
- University of Tennessee Graduate School of Medicine - Knoxville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2024-06-30 |
What the finished NCT06039319 record still lists
NCT06039319 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 492-participant average among 3 other Fetal Growth Retardation trials with a reported enrollment target (92% lower).
The record links to 3 conditions, with Fetal Growth Retardation appearing as the primary indexed condition, and to 1 intervention - of which Physical activity is the first listed.
NCT06039319 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06039319 about?
NCT06039319 is a clinical study titled "Acute Effects of Maternal Exercise and the Growth Restricted Pregnancy". Objectives / Specific Aims * The purpose of this study is to investigate the acute effects of a single bout of moderate intensity maternal exercise on fetal well-being in a pregnancy affected by fetal growth restriction. Fetal well-being will be measured by biophysical profile (BPP), non-stress tes...
What is the current status of trial NCT06039319?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2022-11-01. Estimated completion is 2024-06-30.
What conditions does trial NCT06039319 study?
This clinical trial studies the following conditions: Fetal Growth Retardation, Placental Insufficiency, Fetal Growth Complications.
What interventions are being tested in trial NCT06039319?
The interventions under investigation include: Physical activity (OTHER).
Who is sponsoring clinical trial NCT06039319?
This trial is sponsored by University of Tennessee Graduate School of Medicine, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06039319 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fetal Growth Retardation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI